Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: A population-based analysis of elderly patients

Journal of Clinical Oncology

Volumn 25, Issue 17, 2007, Pages 2389-2396

  Steyerberg, Ewout W ^a   Neville, Bridget ^a   Weeks, Jane C ^a   Earle, Craig C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; AGING; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; REFERRAL AND CONSULTATION; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34347260713     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.7931     Document Type: Article

References (47)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2:533-543, 2001
2. Leonard GD, McCaffrey JA, Maher M: Optimal therapy for oesophageal cancer. Cancer Treat Rev 29:275-282, 2003
3. Wobst A, Audisio RA, Colleoni M, et al: Oesophageal cancer treatment: Studies, strategies and facts. Ann Oncol 9:951-962, 1998
4. Wu PC, Posner MC: The role of surgery in the management of oesophageal cancer. Lancet Oncol 4:481-488, 2003
5. Geh JI: The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 38:300-313, 2002
6. Kaklamanos IG, Walker GR, Ferry K, et al: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754-761, 2003
7. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543, 2003
8. Fiorica F, Di Bona D, Schepis F, et al: Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 53:925-930, 2004
9. Shavers VL, Brown ML: Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334-357, 2002
10. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293-1300, 2003
11. Hodgson DC, Fuchs CS, Ayanian JZ: Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93:501-515, 2001
12. O'Malley CD, Le GM, Glaser SL, et al: Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: A population-based study. Cancer 97:1303-1311, 2003
13. Konety BR, Joslyn SA: Factors influencing aggressive therapy for bladder cancer: An analysis of data from the SEER program. J Urol 170:1765-1771, 2003
14. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, et al: Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 16:767-772, 2005
15. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Age and co-morbidity in cancer patients: A population-based approach. Cancer Treat Res 124:89-107, 2005
16. Baquet CR, Commiskey P, Mack K, et al: Esophageal cancer epidemiology in blacks and whites: Racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 97:1471-1478, 2005
17. Howell EA, Chen YT, Concato J: Differences in cervical cancer mortality among black and white women. Obstet Gynecol 94:509-515, 1999
18. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
19. Shavers VL, Harlan LC, Winn D, et al: Racial/ ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev 22:25-38, 2003
20. Li CI, Malone KE, Daling JR: Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49-56, 2003
21. Cronin-Fenton DP, Sharp L, Carsin AE, et al: Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: A population-based study. Eur J Cancer 43:565-575, 2007
22. Earle CC, Neumann PJ, Gelber RD, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20:1786-1792, 2002
23. Potosky AL, Riley GF, Lubitz JD, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
24. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-IV-18, 2002 (suppl 8)
25. Steyerberg EW, Earle CC, Neville BA, et al: Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: A population-based analysis of elderly patients. J Clin Oncol 23:510-517, 2005
26. Steyerberg EW, Neville BA, Koppert LB, et al: Surgical mortality in patients with esophageal cancer: Development and validation of a simple risk score. J Clin Oncol 24:4277-4284, 2006
27. Cooper GS, Virnig B, Klabunde CN, et al: Use of SEER-Medicare data for measuring cancer surgery. Med Care 40:IV-43-IV-8, 2002 (suppl 8)
28. Virnig BA, Warren JL, Cooper GS, et al: Studying radiation therapy using SEER-Medicare-linked data. Med Care 40:IV-49-IV-54, 2002 (suppl 8)
29. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40:IV-55-IV-61, 2002 (suppl 8)
30. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183:274-279, 2002
31. Klabunde CN, Warren JL, Legler JM: Assessing comorbidity using claims data: An overview. Med Care 40:IV-26-IV-35, 2002 (suppl 8)
32. Arnold AM, Kronmal RA: Multiple imputation of baseline data in the cardiovascular health study. Am J Epidemiol 157:74-84, 2003
33. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
34. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
35. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
36. Bartels H, Stein HJ, Siewert JR: Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85:840-844, 1998
37. Coebergh JW, Janssen-Heijnen ML, Post PN, et al: Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993-1996. J Clin Epidemiol 52:1131-1136, 1999
38. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 55:231-240, 2005
39. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40:IV-19-IV-25, 2002 (suppl 8)
40. Godley PA, Schenck AP, Amamoo MA, et al: Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst 95:1702-1710, 2003
41. Harrell FE Jr, Lee KL, Mark DB: Multivariate prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
42. Rouvelas I, Zeng W, Lindblad M, et al: Survival after surgery for oesophageal cancer: A population-based study. Lancet Oncol 6:864-870, 2005
43. Trivers KF, De Roos AJ, Gammon MD, et al: Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3:225-230, 2005
44. Mettlin CJ, Murphy GP, Cunningham MP, et al: The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer 80:1261-1266, 1997
45. Repetto L, Venturino A, Fratino L, et al: Geriatric oncology: A clinical approach to the older patient with cancer. Eur J Cancer 39:870-880, 2003
46. Finlayson EV, Birkmeyer JD: Operative mortality with elective surgery in older adults. Eff Clin Pract 4:172-177, 2001
47. Repetto L: Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 1:18-24, 2003